|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/12 | (2006.01) |
| A61K2039/5254 | (2013.01) | ||
| A61K2039/55577 | (2013.01) | ||
| C12N2770/24134 | (2013.01) | ||
| A61K 39/12 | (2013.01) | ||
| A61P 31/14 | (2018.01) | ||
| A61P 37/04 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 3236997 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15874179.3 |
| Date of filing the European patent application | 2015-12-18 | |
| (97) | Date of publication of the European application | 2017-11-01 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/066549 |
| Date | 2015-12-18 |
| (87) | Number | WO 2016/106107 |
| Date | 2016-06-30 |
| (30) | Number | Date | Country code |
| 201462095331 P | 2014-12-22 | US |
| (72) |
CASIMIRO, Danilo, R. , US
BETT, Andrew , US
COLLER, Beth-Ann Griswold , US
DHANASEKARAN, Govindarajan , US
CHINTALA, Ramesh, V. , US
|
| (73) |
Merck Sharp & Dohme LLC ,
126 East Lincoln Avenue, Rahway, New Jersey 07065,
US
|
| (54) | DENGUE VIRUS VACCINE COMPOSITIONS AND METHODS OF USE THEREOF |
| DENGUE VIRUS VACCINE COMPOSITIONS AND METHODS OF USE THEREOF |